The Anti-MAGE Antibody B57 as a Diagnostic Marker in Melanocytic Lesions

American Journal of Dermatopathology

Volumn 26, Issue 2, 2004, Pages 102-107

  Kazakov, Dmitry V ^a,c   Kutzner, Heinz ^b   Rütten, Arno ^b   Michal, Michal ^c   Requena, Luis ^d   Burg, Günter ^a   Dummer, Reinhard ^a   Kempf, Werner ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Immunohistochemical markers; MAGE; Melanoma; Nevus

Indexed keywords

FORMALDEHYDE; MELANOMA ANTIGEN 1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B57; PARAFFIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLUE NEVUS; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JUVENILE MELANOMA; MELANOCYTIC NEVUS; MELANOMA; NEVUS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEVUS; SKIN NEOPLASMS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 1842562413     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200404000-00003     Document Type: Article

References (18)

1. Mangini J, Li N, Bhawan J. Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness. Am J Dermatopathol. 2002;24:270-281.
2. Jungbluth AA, Busam KJ, Kolb D, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer. 2000;85:460-465.
3. Kocher T, Schultz-Thater E, Gudat F, et al. Identification and intracellular location of MAGE-3 gene product. Cancer Res. 1995;55:2236-2239.
4. Landry C, Brasseur F, Spagnoli GC, et al. Monoclonal antibody 57B stains tumor tissue that expresses gene MAGE-A4. Int J Cancer. 2000;86:835-841.
5. Resnick MB, Sabo E, Kondratev S, et al. Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinomas and papillary serous carcinomas. Int J Cancer. 2002;101:190-195.
6. Hofbauer GFL, Schaefer C, Noppen C, et al. MAGE-3 immunoreactivity in formalin-fixed, paraffin embedded primary and metastatic melanoma. Am J Pathol. 1997;151:1549-1553.
7. Busam KJ, Iversen K, Berwick M, et al. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters. Mod Pathol. 2000;13:459-465.
8. Barnhill RL. Pathology of Melanocytic Nevi and Malignant Melanoma. Boston, Mass: Butterworth-Heinemann; 1995.
9. Elder DE, Murphy GF. Melanocytic Tumors of the Skin. Washington, DC: Armed Forces Institute of Pathology; 1991.
10. Rodriguez HA, Ackerman LV. Cellular blue nevus. Clinicopathologic study of forty-five cases. Cancer. 1968;21:293-305.
11. Michal M. Cellular blue naevi with microalveolar pattern-a type of naevus frequently confused with melanoma. Pathol Res Pract. 1998;194:83-86.
12. Michal M, Kerekes Z, Kinkor Z, et al. Desmoplastic cellular blue nevus. Am J Dermatopathol. 1995;17:230-235.
13. Carney AJ, Ferreiro JA. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol. 1996;20:259-272.
14. Ball NJ, Golitz LE. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol. 1994;30:724-729.
15. Barr R. Morales, Graham J. Desmoplastic nevus. A distinct histologic variant of mixed spindle and epithelioid cell nevus. Cancer. 1980;46:557-564.
16. Seab JA Jr, Graham JH, Helwig EB. Deep penetrating nevus. Am J Surg Pathol. 1989;13:39-44.
17. Basarab T, Picard JK, Simpson E, et al. Melanoma antigen-encoding gene expression in melanocytic naevi and cutaneous malignant melanomas. Br J Dermatol. 1999;140:106-108.
18. Brasseur F, Rimoldi D, Lienard D, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer. 1995;63:375-380.